Literature DB >> 22503902

Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice.

Virawudh Soontornniyomkij1, Victoria B Risbrough, Jared W Young, Benchawanna Soontornniyomkij, Dilip V Jeste, Cristian L Achim.   

Abstract

Aging-related dysregulation of neuronal calcium metabolism, which not only involves the control of calcium fluxes but also the cytosolic calcium buffering system such as calbindin-1 (Calb1), may disturb synaptic plasticity and thereby memory functioning. Calb1 expression has been shown to affect hippocampal long-term potentiation and learning and to play a neuroprotective role in animal models of ischemic brain injury and neurodegenerative disorders. We hypothesize that memory performance in aged mice correlates with neuronal Calb1 protein expression in the hippocampal formation. We studied a set of 18 aged and 22 young male C57BL/6N mice, in which the aged group performed poorer than the young in single-trial novel object recognition testing (two-tailed p=0.005, U test). Apparent decreases in the Calb1 immunoreactivity (measured by quantitative immunohistochemistry) in aged mice compared to that in young mice were not statistically significant either in the hippocampal CA1 subfield or dentate gyrus. In the aged mouse group, levels of Calb1 immunoreactivity both in the CA1 subfield and dentate gyrus correlated directly with the measure of recognition memory performance (Spearman rank correlation r(s)=0.47 and 0.48, two-tailed p=0.047 and 0.044, respectively). Our results suggest that hippocampal Calb1 expression affects memory performance in aged mice probably via its role in maintaining neuronal calcium homeostasis. Alternatively, our finding of lower Calb1 immunoreactivity with poorer memory performance in aged mice might be attributed to saturation of Calb1 protein by higher levels of intracellular calcium, due to aging-related dysregulation of neuronal calcium fluxes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503902      PMCID: PMC3338865          DOI: 10.1016/j.neulet.2012.03.092

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  34 in total

1.  Intracellular calcium chelation with BAPTA-AM modulates ethanol-induced behavioral effects in mice.

Authors:  Pablo Baliño; Lidón Monferrer; Raúl Pastor; Carlos M G Aragon
Journal:  Exp Neurol       Date:  2012-01-26       Impact factor: 5.330

Review 2.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain.

Authors:  Thomas C Foster
Journal:  Aging Cell       Date:  2007-06       Impact factor: 9.304

Review 3.  Recognition memory and the medial temporal lobe: a new perspective.

Authors:  Larry R Squire; John T Wixted; Robert E Clark
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

4.  Hippocampal interneurons expressing glutamic acid decarboxylase and calcium-binding proteins decrease with aging in Fischer 344 rats.

Authors:  A K Shetty; D A Turner
Journal:  J Comp Neurol       Date:  1998-05-04       Impact factor: 3.215

5.  Age-associated improvements in cross-modal prepulse inhibition in mice.

Authors:  Jared W Young; Chelsea K Wallace; Mark A Geyer; Victoria B Risbrough
Journal:  Behav Neurosci       Date:  2010-02       Impact factor: 1.912

6.  Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia.

Authors:  M A Yenari; M Minami; G H Sun; T J Meier; D M Kunis; J R McLaughlin; D Y Ho; R M Sapolsky; G K Steinberg
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

7.  Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Tatsuhiko Tsunoda; Wataru Satake; Yuko Nakabayashi; Masahiko Watanabe; Atsushi Takeda; Kazuko Hasegawa; Kenji Nakashima; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Genet       Date:  2008-06-22       Impact factor: 4.132

8.  Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia.

Authors:  Y Ichimiya; P C Emson; C Q Mountjoy; D E Lawson; C W Heizmann
Journal:  Brain Res       Date:  1988-12-13       Impact factor: 3.252

9.  Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects.

Authors:  K A Maguire-Zeiss; Z W Li; L M Shimoda; R W Hamill
Journal:  Brain Res Mol Brain Res       Date:  1995-06

10.  Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression.

Authors:  S Molinari; R Battini; S Ferrari; L Pozzi; A S Killcross; T W Robbins; A Jouvenceau; J M Billard; P Dutar; Y Lamour; W A Baker; H Cox; P C Emson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

View more
  16 in total

Review 1.  Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.

Authors:  Wanda M Snow; Brenda M Stoesz; Debbie M Kelly; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2013-10-13       Impact factor: 5.590

Review 2.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

3.  Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.

Authors:  Benjamin S McKenna; Gregory G Brown; Sarah Archibald; Miriam Scadeng; Robert Bussell; James P Kesby; Athina Markou; Virawudh Soontornniyomkij; Cristian Achim; Svetlana Semenova
Journal:  Psychiatry Res Neuroimaging       Date:  2016-02-24       Impact factor: 2.376

4.  Loss of Immunohistochemical Reactivity in Association With Handling-Induced Dark Neurons in Mouse Brains.

Authors:  Virawudh Soontornniyomkij; Rachel C Chang; Benchawanna Soontornniyomkij; Jan M Schilling; Hemal H Patel; Dilip V Jeste
Journal:  Toxicol Pathol       Date:  2020-01-03       Impact factor: 1.902

5.  Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.

Authors:  Patricia Rivera; Sergio Arrabal; Antonio Vargas; Eduardo Blanco; Antonia Serrano; Francisco J Pavón; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Neuroanat       Date:  2014-03-17       Impact factor: 3.856

6.  Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.

Authors:  Christian Wächter; Lee E Eiden; Nedye Naumann; Candan Depboylu; Eberhard Weihe
Journal:  J Neuroinflammation       Date:  2016-10-14       Impact factor: 8.322

7.  Role of Satb1 and Satb2 Transcription Factors in the Glutamate Receptors Expression and Ca2+ Signaling in the Cortical Neurons In Vitro.

Authors:  Egor A Turovsky; Maria V Turovskaya; Evgeniya I Fedotova; Alexey A Babaev; Viktor S Tarabykin; Elena G Varlamova
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

8.  Distinct synaptic and neurochemical changes to the granule cell-CA3 projection in Bassoon mutant mice.

Authors:  Sandra Dieni; Sigrun Nestel; Mirjam Sibbe; Michael Frotscher; Sabine Hellwig
Journal:  Front Synaptic Neurosci       Date:  2015-10-23

9.  Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.

Authors:  Maura Barbisin; Silvia Vanni; Ann-Christin Schmädicke; Judith Montag; Dirk Motzkus; Lennart Opitz; Gabriela Salinas-Riester; Giuseppe Legname
Journal:  BMC Genomics       Date:  2014-06-05       Impact factor: 3.969

10.  Effects of long‑term scopolamine treatment on cognitive deficits and calcium binding proteins immunoreactivities in the mouse hippocampus.

Authors:  Ji Hyeon Ahn; Bai Hui Chen; Bing Chun Yan; Joon Ha Park; Il Jun Kang; Tae-Kyeong Lee; Jeong Hwi Cho; Bich-Na Shin; Jae-Chul Lee; Yong Hwan Jeon; Seongkweon Hong; Young Joo Lee; Soo Young Choi; Moo-Ho Won
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.